cryptotanshinone has been researched along with Encephalopathy, Toxic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, J; Chan, E; Chen, X; Chowbay, B; Duan, W; Li, CG; Liang, J; Lin, SG; Wen, JY; Yu, XY; Zhou, SF; Zhou, ZW | 1 |
1 other study(ies) available for cryptotanshinone and Encephalopathy, Toxic
| Article | Year |
|---|---|
Transport of cryptotanshinone, a major active triterpenoid in Salvia miltiorrhiza Bunge widely used in the treatment of stroke and Alzheimer's disease, across the blood-brain barrier.
Topics: Alzheimer Disease; Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Biological Transport; Blood-Brain Barrier; Brain; Capillary Permeability; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Endothelial Cells; Infarction, Middle Cerebral Artery; Male; Mice; Mice, Knockout; Microcirculation; Multidrug Resistance-Associated Proteins; Neuroprotective Agents; Neurotoxicity Syndromes; Phenanthrenes; Plant Roots; Quinolinic Acid; Rats; Rats, Sprague-Dawley; Salvia miltiorrhiza; Stroke; Tissue Distribution; Triterpenes | 2007 |